Evidence map›Paper›PMID 38094602›Full record

ArticleFrontiers in oncology2023

Global research trends of the application of artificial intelligence in bladder cancer since the 21st century: a bibliometric analysis.

Yingjian Zhou, Wenchao Xu, Yan Zeng, Hao Li, Zhuo Liu, Tao Wang, Jihong Liu, Hongyang Jiang

Abstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yingjian Zhou *Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wenchao Xu *Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yan Zeng *Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hao LiDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhuo LiuDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Tao WangDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jihong LiuDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Hongyang JiangDepartment of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Since the significant breakthroughs in artificial intelligence (AI) algorithms, the application of AI in bladder cancer has rapidly expanded. AI can be used in all aspects of the bladder cancer field, including diagnosis, treatment and prognosis prediction. Nowadays, these technologies have an excellent medical auxiliary effect and are in explosive development, which has aroused the intense interest of researchers. This study will provide an in-depth analysis using bibliometric analysis to explore the trends in this field. Method: Documents regarding the application of AI in bladder cancer from 2000 to 2022 were searched and extracted from the Web of Science Core Collection. These publications were analyzed by bibliometric analysis software (CiteSpace, Vosviewer) to visualize the relationship between countries/regions, institutions, journals, authors, references, keywords. Results: We analyzed a total of 2368 publications. Since 2016, the number of publications in the field of AI in bladder cancer has increased rapidly and reached a breathtaking annual growth rate of 43.98% in 2019. The U.S. has the largest research scale, the highest study level and the most significant financial support. The University of North Carolina is the institution with the highest level of research. EUROPEAN UROLOGY is the most influential journal with an impact factor of 24.267 and a total citation of 11,848. Wiklund P. has the highest number of publications, and Menon M. has the highest number of total citations. We also find hot research topics within the area through references and keywords analysis, which include two main parts: AI models for the diagnosis and prediction of bladder cancer and novel robotic-assisted surgery for bladder cancer radicalization and urinary diversion. Conclusion: AI application in bladder cancer is widely studied worldwide and has shown an explosive growth trend since the 21st century. AI-based diagnostic and predictive models will be the next protagonists in this field. Meanwhile, the robot-assisted surgery is still a hot topic and it is worth exploring the application of AI in it. The advancement and application of algorithms will be a massive driving force in this field.

Indexed as

artificial intelligencebibliometric analysisbladder cancerCiteSpacerobotic surgeryVOSviewer

Identifiers

PMID38094602
PMCPMC10718619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.